Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Hepatitis C

  Free Subscription


21.05.2018

2 Enferm Infecc Microbiol Clin
2 Eur J Gastroenterol Hepatol
2 J Hepatol
3 J Viral Hepat
1 Lancet Gastroenterol Hepatol
1 Transplantation


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Enferm Infecc Microbiol Clin

  1. LAZARUS JV, Bromberg DJ, Del Amo J, Norgaard O, et al
    Hepatitis C prevalence among the immigrant population in Spain: A systematic review and meta-analysis.
    Enferm Infecc Microbiol Clin. 2018 May 11. pii: S0213-005X(18)30171.
    PubMed     Text format     Abstract available

  2. NAVARRO-DE LA CRUZ D, Perez-Castro S, Trigo-Daporta M, Aguilera-Guirao A, et al
    Prevalence and distribution of hepatitis C virus genotypes in Galicia during the period 2000-2015.
    Enferm Infecc Microbiol Clin. 2018 May 11. pii: S0213-005X(18)30166.
    PubMed     Text format     Abstract available


    Eur J Gastroenterol Hepatol

  3. ISAKOV V, Paduta D, Viani RM, Enejosa JV, et al
    Ombitasvir/paritaprevir/ritonavir+dasabuvir+ribavirin for chronic hepatitis C virus genotype 1b-infected cirrhotics (TURQUOISE-IV).
    Eur J Gastroenterol Hepatol. 2018 May 14. doi: 10.1097/MEG.0000000000001166.
    PubMed     Text format     Abstract available

  4. POGORZELSKA J, Lapinska M, Kalinowska A, Lapinski TW, et al
    Helicobacter pylori infection among patients with liver cirrhosis.
    Eur J Gastroenterol Hepatol. 2017 Jul 11. doi: 10.1097/MEG.0000000000000928.
    PubMed     Text format     Abstract available


    J Hepatol

  5. BUGGISCH P, Zeuzem S
    Real-world effectiveness of 8 weeks treatment with ledipasvir/sofosbuvir in chronic hepatitis C.
    J Hepatol. 2018 May 11. pii: S0168-8278(18)32051.
    PubMed     Text format     Abstract available

  6. BELLI LS, Duvoux C, Berg T, Strazzabosco M, et al
    ELITA consensus statements on use of DAAs in liver transplant candidates and recipients.
    J Hepatol. 2017 Mar 18. pii: S0168-8278(17)30140.
    PubMed     Text format     Abstract available


    J Viral Hepat

  7. CARDOSO AC, Perez RM, de Figueiredo-Mendes C, Carvalho Leite N, et al
    Prevalence and predictive factors of moderate/severe liver steatosis in chronic hepatitis C (CHC) infected patients evaluated with Controlled Attenuation Parameter (CAP).
    J Viral Hepat. 2018 May 16. doi: 10.1111/jvh.12930.
    PubMed     Text format     Abstract available

  8. JEONG Y, Jin B, Lee HW, Park HJ, et al
    Evolution and Persistence of the Resistance-Associated Substitutions of Hepatitis C Virus after Direct-Acting Antiviral Treatment Failures.
    J Viral Hepat. 2018 May 16. doi: 10.1111/jvh.12932.
    PubMed     Text format     Abstract available

  9. DEMING R, Ford MM, Moore MS, Lim S, et al
    Evaluation of a hepatitis C clinical care coordination program's effect on treatment initiation and cure: A surveillance-based propensity score matching approach.
    J Viral Hepat. 2018 May 14. doi: 10.1111/jvh.12929.
    PubMed     Text format     Abstract available


    Lancet Gastroenterol Hepatol

  10. YANG JD, Mohamed EA, Aziz AO, Shousha HI, et al
    Characteristics, management, and outcomes of patients with hepatocellular carcinoma in Africa: a multicountry observational study from the Africa Liver Cancer Consortium.
    Lancet Gastroenterol Hepatol. 2017;2:103-111.
    PubMed     Text format     Abstract available


    Transplantation

  11. TUCCI A, Rizza S, Cocchis D, Martini S, et al
    Early and late hepatitis B reactivation following IFN- or DAA-based therapy of recurrent hepatitis C in anti-HBc-positive liver transplant recipients.
    Transplantation. 2018 May 2. doi: 10.1097/TP.0000000000002241.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis C is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: